Bartell Drugs to offer free health screenings at 11 of its stores in Feb.
SEATTLE Bartell Drugs, which operates stores in the Seattle area, said it would offer free health screenings at 11 of its stores next month. The stores will offer tests for blood glucose, cholesterol and blood pressure in partnership with One Touch, Nature Made and CIA Health Screenings. Customers will receive results immediately.
“We are extremely pleased to offer these screenings, because the results can provide our customers with important front-line indicators in the fight against diabetes, heart disease and stroke,” chairman and CEO George Bartell said in a statement.
The screenings will take place from 10 a.m. to 4 p.m. every day of the month starting Feb. 16.
FDA approves generic version of Depakote
ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of Abbott’s Depakote, FDA records show.
The agency approved Dr. Reddy’s Labs divalproex sodium delayed-release capsules in the 125 mg strength. The capsules are used to treat epilepsy, bipolar disorder and migraine headaches.
The branded version of the drug had sales of $1.5 billion in 2007, according to Abbott financial records.
FDA approves Mylan’s generic epilepsy drug
PITTSBURGH The Food and Drug Administration has approved Mylan’s generic version of GlaxoSmithKline’s epilepsy drug Lamictal, Mylan announced Wednesday.
The drug, known generically as lamotrigine, is also used to treat bipolar disorder. Mylan will sell the drug in the 25 mg, 100 mg, 150 mg and 200 mg strengths. The FDA also approved Genpharm?s application for a chewable generic version of Lamictal.
The branded version of the drug had sales of about $91 million in the year ending Sept. 30, according to IMS Health.